Jeong Se Kyoo, Kim Hyun Jeong, Youm Jong-Kyung, Ahn Sung Ku, Choi Eung Ho, Sohn Myung Hyun, Kim Kyu-Earn, Hong Jeong Hee, Shin Dong Min, Lee Seung Hun
Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.
J Invest Dermatol. 2008 Aug;128(8):1930-9. doi: 10.1038/jid.2008.13. Epub 2008 Feb 28.
Protease-activated receptor-2 (PAR-2) is known to be involved in epidermal permeability barrier function homeostasis. PAR-2 activation occurs after barrier disruption and further activation of PAR-2 by activating peptide significantly delays barrier recovery rate. Cockroach and house dust mite allergens, both known to be associated with the development of asthma, allergic rhinitis, and atopic dermatitis, have protease activity, which can activate PAR-2. In this study, we investigated the effects of both allergens on the epidermal barrier function as well as on the epidermal calcium gradient. Both allergens, when topically applied on the barrier-disrupted site, increased protease activities in the epidermis and delayed barrier recovery and lamellar body secretion in murine skin. The topical application of PAR-2-specific antagonist or protease inhibitors normalized the barrier recovery. Cockroach allergens induced intracellular calcium oscillations in cultured human keratinocytes through PAR-2-involved pathway, which was confirmed by desensitization protocol. Abnormal calcium ion distribution after barrier disruption was also observed in allergens-applied skin. These results suggest that allergens with protease activity can influence the epidermal permeability barrier homeostasis through PAR-2 activation and consequent modulation of the calcium ions in skin.
蛋白酶激活受体-2(PAR-2)已知参与表皮通透性屏障功能的稳态。屏障破坏后PAR-2被激活,且激活肽进一步激活PAR-2会显著延迟屏障恢复速率。蟑螂和屋尘螨过敏原都与哮喘、过敏性鼻炎和特应性皮炎的发病有关,它们具有蛋白酶活性,能够激活PAR-2。在本研究中,我们调查了这两种过敏原对表皮屏障功能以及表皮钙梯度的影响。当将这两种过敏原局部应用于屏障破坏部位时,它们均增加了表皮中的蛋白酶活性,并延迟了小鼠皮肤的屏障恢复和板层小体分泌。局部应用PAR-2特异性拮抗剂或蛋白酶抑制剂可使屏障恢复正常。蟑螂过敏原通过PAR-2相关途径在培养的人角质形成细胞中诱导细胞内钙振荡,脱敏实验证实了这一点。在应用过敏原的皮肤中还观察到屏障破坏后钙离子分布异常。这些结果表明,具有蛋白酶活性的过敏原可通过激活PAR-2以及随后调节皮肤中的钙离子来影响表皮通透性屏障的稳态。